Craft

Universal Biosensors

Stock Price

$0.1

2024-10-24

Market Capitalization

$41.7 M

2024-10-24

Revenue

$6.3 M

FY, 2024

Universal Biosensors Summary

Company Summary

Overview
Universal Biosensors (UBI) is focused on the research, development, and manufacture of diagnostic test systems for point-of-care (POC) professional and home use. UBI’s core technology is a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures biomarkers in the blood. This technology offers speed, ease of use, reliability, and accuracy at a low cost.
Type
Public
Status
Active
Founded
2001
HQ
Rowville, AU | view all locations
Website
http://www.universalbiosensors.com/
Cybersecurity rating
Sectors

Key People

  • Craig Coleman

    Craig Coleman, Non-Executive Director

    • John Sharman
    • Philip Fiorillo

      Philip Fiorillo, General Manager

    • Salesh Balak

      Salesh Balak, CFO & Company Secretary

    LocationsView all

    1 location detected

    • Rowville, Victoria HQ

      Australia

      1 Corporate Ave

    Universal Biosensors Financials

    Summary Financials

    Revenue (Q2, 2025)
    $1.2M
    Gross profit (Q2, 2025)
    ($1.2M)
    Net income (Q2, 2025)
    ($6.6M)
    Cash (Q2, 2025)
    $2.2M
    EBIT (Q2, 2025)
    ($6.7M)
    Enterprise value
    $42.4M

    Footer menu